ライフサイエンスコーパス: Chlamydia trachomatis

1 ion with the obligate intracellular bacteria Chlamydia trachomatis.

2 -to-culture, obligate intracellular pathogen Chlamydia trachomatis.

3 re compared to Amplicor for detecting ocular Chlamydia trachomatis.

4 ysis of 52 geographically diverse strains of Chlamydia trachomatis.

5 ellular pathogens Listeria monocytogenes and Chlamydia trachomatis.

6 he obligate intracellular bacterial pathogen Chlamydia trachomatis.

7 uitous in many chlamydial species, including Chlamydia trachomatis.

8 lls for the obligate intracellular bacterium Chlamydia trachomatis.

9 fected with a single cervical inoculation of Chlamydia trachomatis.

10 is often found in the absence of detectable Chlamydia trachomatis.

11 munofibrogenic disease process, initiated by Chlamydia trachomatis.

12 xual transmission is probably lower than for Chlamydia trachomatis.

13 eded to prevent the oculogenital diseases of Chlamydia trachomatis.

14 members in the sexually transmitted pathogen Chlamydia trachomatis.

15 nesis of the obligate intracellular bacteria Chlamydia trachomatis.

16 were screened for Neisseria gonorrhoeae and Chlamydia trachomatis.

17 a model for investigating the human pathogen Chlamydia trachomatis.

18 ant role of antibodies in protection against Chlamydia trachomatis.

19 is triggered by diverse bacteria, including Chlamydia trachomatis, a frequent intracellular parasite

20 In the class I-c beta subunit from Chlamydia trachomatis, a heterodinuclear Mn(II)/Fe(II) c

21 Chlamydia trachomatis, a leading bacterial cause of sexu

22 Chlamydia trachomatis, a pathogen responsible for diseas

23 acid amplification tests (NAATs) that detect Chlamydia trachomatis AC2 also detects Neisseria gonorrh

24 ind that C. muridarum and the human pathogen Chlamydia trachomatis activate not only NLRP3 but also A

25 lesion, and changes in sexual behaviors and Chlamydia trachomatis, an infection with similar epidemi

26 is produced by chronic ocular infection with Chlamydia trachomatis, an obligate intracellular bacteri

27 (Versant CT/GC assay, where "CT" represents Chlamydia trachomatis and "GC" represents Neisseria gono

28 RealTime CT/NG assay (where "CT" stands for Chlamydia trachomatis and "NG" stands for Neisseria gono

29 iable analysis were vaccine status, positive Chlamydia trachomatis and >/=4 partners in the preceding

30 Lower genital tract infection with Chlamydia trachomatis and C. muridarum can induce long-l

31 reviewed recently, but the detailed roles of Chlamydia trachomatis and C. pneumoniae in induction of

32 Plasmid-free Chlamydia trachomatis and Chlamydia muridarum fail to in

33 udy was to assess the prevalence of synovial Chlamydia trachomatis and Chlamydia pneumoniae infection

34 Chlamydia trachomatis and Chlamydophila (Chlamydia) pneu

35 Chlamydia trachomatis and Mycoplasma genitalium coinfect

36 The next-generation amplification test for Chlamydia trachomatis and Neisseria gonorrhoeae (Roche c

37 se of infertility and ectopic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are reco

38 of self-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by a tra

39 assay (ATV; Gen-Probe) and the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae coinfect

40 methods exist for the molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clini

41 ilable molecular assays for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in recta

42 The assay simultaneously detects Chlamydia trachomatis and Neisseria gonorrhoeae in swab

43 with detectable T. vaginalis, codetection of Chlamydia trachomatis and Neisseria gonorrhoeae occurred

44 utilization of nontraditional locations for Chlamydia trachomatis and Neisseria gonorrhoeae screenin

45 Patients were evaluated for Chlamydia trachomatis and Neisseria gonorrhoeae using NA

46 T) has become the preferred method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no

47 ing (NAAT) is the preferred method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no

48 isease associations, which parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mec

49 Tests for Chlamydia trachomatis and Neisseria gonorrhoeae, which c

50 ime PCR assay, for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

51 of the two most common bacterial infections: Chlamydia trachomatis and Neisseria gonorrhoeae.

52 ) nonameric epitopes that span the genome of Chlamydia trachomatis and prepared MHC tetramers from ap

53 Chlamydia trachomatis and smoking are major risk factors

54 Female pig-tailed macaques inoculated with Chlamydia trachomatis and Trichomonas vaginalis (n = 9)

55 tigated whether coinfection of macaques with Chlamydia trachomatis and Trichomonas vaginalis decrease

56 e laboratory-detected Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infecti

57 ification testing for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis were pe

58 Although most individuals infected with Chlamydia trachomatis are initially asymptomatic, sympto

59 he obligate intracellular bacterial parasite Chlamydia trachomatis are the same as its eukaryotic hos

60 Neisseria gonorrhoeae and Chlamydia trachomatis are well-documented urethral patho

61 l children, such as Neisseria gonorrhoeae or Chlamydia trachomatis, are due to abusive contact and sh

62 tively restrict growth of the human pathogen Chlamydia trachomatis but fails to control growth of the

63 urethritis (NGU) and cervicitis is aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which

64 We recently detected PG in Chlamydia trachomatis by a new metabolic cell wall label

65 In both Chlamydia trachomatis (C. trachomatis) and C. pneumoniae

66 female infertility and genital infection by Chlamydia trachomatis (C. trachomatis) is a major cause.

67 mation of the membrane of the human pathogen Chlamydia trachomatis (C.t.).

68 Chlamydia trachomatis can enter a viable but nonculturab

69 Ocular infection with Chlamydia trachomatis can lead to trachoma, a leading in

70 Chlamydia trachomatis causes both trachoma and sexually

71 Chlamydia trachomatis causes chronic inflammatory diseas

72 Chlamydia trachomatis causes sexually transmitted infect

73 sex or symptoms is used to manage anorectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrho

74 Chlamydia trachomatis conjunctivitis may present with ex

75 Chlamydia trachomatis contains a conserved approximately

76 The class Ic RNR from the human pathogen Chlamydia trachomatis ( Ct) uses a Mn (IV)/Fe (III) cofa

77 The class Ic ribonucleotide reductase from Chlamydia trachomatis ( Ct) uses a stable Mn(IV)/Fe(III)

78 hose who have not been diagnosed with rectal Chlamydia trachomatis (CT) and/or rectal Neisseria gonor

79 Although Chlamydia trachomatis (Ct) can infect the placenta and d

80 Chlamydia trachomatis (Ct) has been associated with misc

81 The obligate-intracellular pathogen Chlamydia trachomatis (Ct) has undergone considerable ge

82 he diagnosis and management of uncomplicated Chlamydia trachomatis (CT) infection in adolescents and

83 Genital Chlamydia trachomatis (Ct) infection induces protective

84 study was to estimate the probability that a Chlamydia trachomatis (CT) infection will cause an episo

85 The frequency and duration of Chlamydia trachomatis (Ct) ocular infections decrease wi

86 Chlamydia trachomatis (Ct) remains the leading global ca

87 collected for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) screening of HIV-1-infected M

88 odel of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (CT) transmission dynamics among M

89 class Ic ribonucleotide reductase (RNR) from Chlamydia trachomatis (Ct) utilizes a Mn/Fe heterobinucl

90 Urine was tested for Chlamydia trachomatis (CT), Mycoplasma genitalium (MG),

91 Chlamydia trachomatis (CT), Mycoplasma genitalium (MG),

92 mSIBA) that allows simultaneous detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG),

93 In the class Ic enzyme from Chlamydia trachomatis (Ct), the cysteine oxidant is the

94 An example is infection with Chlamydia trachomatis (Ct), which is the most common sex

95 We tested 30 potentially Chlamydia trachomatis (CT)-infected patients in a hospit

96 es this function in the class Ic enzyme from Chlamydia trachomatis (Ct).

97 Trachoma is caused by Chlamydia trachomatis (Ct).

98 tercourse for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT).

99 The obligate intracellular pathogen Chlamydia trachomatis (Ctr) is a major cause of sexually

100 ured derivative of the human genital isolate Chlamydia trachomatis D/UW-3/Cx, strain CTD153, which al

101 Obligate intracellular bacteria such as Chlamydia trachomatis depend on metabolites of the host

102 Repeat Chlamydia trachomatis detection frequently occurs within

103 her probenecid would have a direct effect on Chlamydia trachomatis development through inhibition of

104 We examined the promoters for 10 Chlamydia trachomatis early genes and found that they co

105 We used a Chlamydia trachomatis elementary body (EB)-based enzyme-

106 Chlamydia trachomatis elementary body enzyme-linked immu

107 In contrast, the human pathogen Chlamydia trachomatis encodes only two nucleotide transp

108 bacter baumannii, Burkholderia pseudomallei, Chlamydia trachomatis, Escherichia coli, Klebsiella pneu

109 oring indicates an absence of infection with Chlamydia trachomatis even if FT persists, may be more c

110 erinary relatives, the oculogenital pathogen Chlamydia trachomatis evolved as a commensal organism of

111 o, the obligate intracellular human pathogen Chlamydia trachomatis exhibits elevated expression of a

112 The human pathogen Chlamydia trachomatis exists as multiple serovariants th

113 Chlamydia trachomatis exits host epithelial cells throug

114 ancient neglected tropical disease caused by Chlamydia trachomatis for which a vaccine is needed.

115 s for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pharyngeal and rectal specime

116 ances detection of Neisseria gonorrhoeae and Chlamydia trachomatis from rectal and pharyngeal sources

117 Chlamydia trachomatis genital infection is a worldwide p

118 oncerning prevalence and disease severity of Chlamydia trachomatis genital infection is whether more

119 finding and treating prevalent, asymptomatic Chlamydia trachomatis genital infection reduces reproduc

120 ancy and infertility observed in women after Chlamydia trachomatis genital infection result from asce

121 nd treatment programs implemented to control Chlamydia trachomatis genital infections and their compl

122 The majority of Chlamydia trachomatis genital infections in humans are a

123 Chlamydia trachomatis genital tract infection is a major

124 isting of 908 open reading frames encoded in Chlamydia trachomatis genome and plasmid was used to pro

125 fy novel transcriptional regulators from the Chlamydia trachomatis genome by predicting proteins with

126 The human pathogen Chlamydia trachomatis grows in a glycogen-rich vacuole.

127 .09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 92% lower odds of any adverse

128 The obligate intracellular parasite Chlamydia trachomatis has a reduced genome and is though

129 The obligate intracellular parasite Chlamydia trachomatis has a reduced genome but relies on

130 tive plasmid of both Chlamydia muridarum and Chlamydia trachomatis has been shown to control virulenc

131 rinary tract of mice with a human serovar of Chlamydia trachomatis has not been characterized.

132 We show that a LipL2 enzyme from Chlamydia trachomatis has similar activity, demonstratin

133 hock proteins of the intracellular bacterium Chlamydia trachomatis have been associated with immune p

134 Tests for ocular Chlamydia trachomatis have not been well characterized,

135 Chlamydia trachomatis (hazard ratio [HR], 3.14; 95% conf

136 d infections, such as Neisseria gonorrhoeae, Chlamydia trachomatis, HIV, human papillomavirus (HPV) a

137 atural infection induces partial immunity to Chlamydia trachomatis Identification of chlamydial antig

138 Repeated episodes of infection with Chlamydia trachomatis in childhood lead to severe conjun

139 is caused by recurrent ocular infection with Chlamydia trachomatis in childhood, with conjunctival sc

140 he prevalence of trachoma and infection with Chlamydia trachomatis in communities after 3-7 years of

141 Urogenital infection with Chlamydia trachomatis in some women can lead to upper ge

142 nts of the genetically intransigent pathogen Chlamydia trachomatis, in which all mutations have been

143 The immunopathogenesis of Chlamydia trachomatis-induced oviduct pathological seque

144 inflammatory mediator, ATP, is released from Chlamydia trachomatis-infected epithelial cells.

145 Women who tested positive for Chlamydia trachomatis infection after having been contac

146 ned whether TLR variants are associated with Chlamydia trachomatis infection among women with pelvic

147 nces about the true population prevalence of Chlamydia trachomatis infection and disease and the sens

148 A sensing directs IFN-beta expression during Chlamydia trachomatis infection and suggest that effecto

149 ate point-of-care (POC) diagnostic tests for Chlamydia trachomatis infection are urgently needed for

150 rance and confer protective immunity against Chlamydia trachomatis infection but have not been simult

151 Conjunctival Chlamydia trachomatis infection causes scarring, entropi

152 witnessed a disturbing increase in cases of Chlamydia trachomatis infection despite enhanced control

153 served signs of trachomatous inflammation or Chlamydia trachomatis infection diagnosed using PCR.

154 ral discharge to diagnose N. gonorrhoeae and Chlamydia trachomatis infection in certain populations b

155 correctly measure the true status of ocular Chlamydia trachomatis infection in individuals, particul

156 Chlamydia trachomatis infection in the lower genital tra

157 interleukin-8 (IL-8) response induced during Chlamydia trachomatis infection is not known.

158 The role of organism load in Chlamydia trachomatis infection is not well understood.

159 Chlamydia trachomatis infection is the most common bacte

160 Chlamydia trachomatis infection is the most common bacte

161 Chlamydia trachomatis infection is the most common sexua

162 Chlamydia trachomatis infection is the most common sexua

163 Urogenital Chlamydia trachomatis infection remains prevalent and ca

164 evaluated for trachoma, and determination of Chlamydia trachomatis infection was made.

165 Chlamydia trachomatis infection, the most common reporta

166 w-up studies in a murine model of intranasal Chlamydia trachomatis infection, we analogously found th

167 ation of women notified by a sex partner for Chlamydia trachomatis infection.

168 d concern about efficacy of azithromycin for Chlamydia trachomatis infection.

169 rchers, and epidemiologists studying genital Chlamydia trachomatis infection.

170 kg) was administered for treatment of ocular Chlamydia trachomatis infection.

171 We developed a ddPCR assay for Chlamydia trachomatis infections and found it to be accu

172 Repeated Chlamydia trachomatis infections are common among young

173 While Chlamydia trachomatis infections are frequently asymptom

174 Chlamydia trachomatis infections can lead to severe chro

175 Chlamydia trachomatis infections cause severe and irreve

176 ociated with pathological sequelae of ocular Chlamydia trachomatis infections in The Gambia.

177 Genital Chlamydia trachomatis infections in women typically are

178 en at high risk for Neisseria gonorrhoeae or Chlamydia trachomatis infections.

179 ed to implement a vaccine to protect against Chlamydia trachomatis infections.

180 this study, we show that the human pathogen Chlamydia trachomatis infects the murine respiratory and

181 Chlamydia trachomatis is a genetically intractable oblig

182 The bacterial pathogen Chlamydia trachomatis is a global health burden currentl

183 Chlamydia trachomatis is a global health burden due to i

184 Chlamydia trachomatis is a globally important obligate i

185 Chlamydia trachomatis is a Gram-negative obligate intrac

186 Chlamydia trachomatis is a human pathogen of global impo

187 Chlamydia trachomatis is a leading cause of genital and

188 Chlamydia trachomatis is a medically important pathogen

189 Chlamydia trachomatis is a pathogen responsible for a pr

190 Chlamydia trachomatis is among the most clinically signi

191 Chlamydia trachomatis is an important cause of sexually

192 Chlamydia trachomatis is an important human pathogen tha

193 Chlamydia trachomatis is an important risk factor for PI

194 Chlamydia trachomatis is an obligate intracellular bacte

195 Chlamydia trachomatis is an obligate intracellular bacte

196 Chlamydia trachomatis is an obligate intracellular bacte

197 Chlamydia trachomatis is an obligate intracellular epith

198 Chlamydia trachomatis is an obligate intracellular human

199 Chlamydia trachomatis is an obligate intracellular human

200 Chlamydia trachomatis is an obligate intracellular mucos

201 Chlamydia trachomatis is an obligate intracellular paras

202 Chlamydia trachomatis is an obligate intracellular patho

203 Chlamydia trachomatis is an obligate intracellular patho

204 Chlamydia trachomatis is an obligate intracellular patho

205 Chlamydia trachomatis is an obligate intracellular patho

206 Chlamydia trachomatis is considered the most common agen

207 on with the obligate intracellular bacterium Chlamydia trachomatis is controlled primarily by IFN-gam

208 current or long-term infections of humans by Chlamydia trachomatis is poorly understood.

209 Chlamydia trachomatis is responsible for both trachoma a

210 Chlamydia trachomatis is responsible for sexually transm

211 The obligate intracellular human pathogen Chlamydia trachomatis is the etiological agent of blindi

212 Chlamydia trachomatis is the etiological agent of tracho

213 Chlamydia trachomatis is the leading cause of infection-

214 Chlamydia trachomatis is the leading cause of infectious

215 Chlamydia trachomatis is the leading infectious cause of

216 The obligate intracellular bacterium Chlamydia trachomatis is the most common cause of bacter

217 Chlamydia trachomatis is the most common notifiable dise

218 Chlamydia trachomatis is the most common sexually transm

219 Chlamydia trachomatis is the world's most prevalent bact

220 a, caused by repeated infections with ocular Chlamydia trachomatis, is targeted for elimination using

221 aused by the obligate intracellular organism Chlamydia trachomatis, is the world's leading cause of p

222 Chlamydia trachomatis isolates that cause trachoma, sexu

223 Chlamydia trachomatis isolates were obtained before and

224 , increased the growth of the human pathogen Chlamydia trachomatis (L2) in wild-type murine fibroblas

225 pecifically bound and repressed promoters of Chlamydia trachomatis late genes, but not early or mid g

226 Infection of the cells by Chlamydia trachomatis leads to activation of caspase-1,

227 he obligate bacterial intracellular pathogen Chlamydia trachomatis leads to the sustained activation

228 As is the case in Chlamydia trachomatis LpxD (CtLxpD), each EcLpxD chain c

229 f bound UDP-GlcNAc in the X-ray structure of Chlamydia trachomatis LpxD.

230 The VD4 region from the Chlamydia trachomatis major outer membrane protein conta

231 Chlamydia muridarum and Chlamydia trachomatis mouse models of genital infection

232 Monoclonal antibodies (MAbs) to the Chlamydia trachomatis mouse pneumonitis (MoPn) major out

233 assessed the intervention effect on incident Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycopl

234 s, the prevalences of Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

235 a, and first-void female urine specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

236 sites were tested for M. genitalium and for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

237 e new insights concerning the concurrence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma

238 uently drink alcohol and to be infected with Chlamydia trachomatis, Neisseria gonorrhoeae, or herpes

239 d for M. genitalium and other STI organisms (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomona

240 ed with those for batches of 24 samples; for Chlamydia trachomatis/Neisseria gonorrhoeae tests, the a

241 e the immunogenicity and vaccine efficacy of Chlamydia trachomatis nMOMP in a nonhuman primate tracho

242 rs) was significantly greater than those for Chlamydia trachomatis or N. gonorrhoeae (27.6 and 25.9 y

243 e a significant association with concomitant Chlamydia trachomatis or N. gonorrhoeae infection overal

244 We previously reported that the Chlamydia trachomatis outer membrane complex protein B (

245 The Chlamydia trachomatis outer membrane complex protein B (

246 amples were collected for bacterial culture, Chlamydia trachomatis PCR, and RNA isolation at 1 year.

247 ed on filter paper to test for antibodies to Chlamydia trachomatis pgp3 using a multiplex bead assay.

248 The Chlamydia trachomatis plasmid is a virulence factor.

249 Human antibody recognition of Chlamydia trachomatis plasmid-encoded Pgp3 protein is de

250 Chlamydia trachomatis possesses a cryptic 7.5-kb plasmid

251 A new R2 subclass, R2c, prototyped by the Chlamydia trachomatis protein was recently discovered.

252 Comparator assays included BD ProbeTec Chlamydia trachomatis Q(x) (CTQ)/Neisseria gonorrhoeae Q

253 Chlamydia trachomatis remains a leading cause of bacteri

254 Obligate intracellular Chlamydia trachomatis replicate in a membrane-bound vacu

255 he bacterial obligate intracellular pathogen Chlamydia trachomatis replicates within a membrane-bound

256 The recent success in transformation of Chlamydia trachomatis represents a major advancement in

257 cal setting: infection of myeloid cells with Chlamydia trachomatis resulted in the expression of CHOP

258 source, molecular Neisseria gonorrhoeae and Chlamydia trachomatis results, and relative light unit (

259 nd Mn(III)Fe(III) sites in the R2 subunit of Chlamydia trachomatis ribonucleotide reductase using x-r

260 The Mn(IV)/Fe(III) cofactor of Chlamydia trachomatis RNR assembles via a Mn(IV)/Fe(IV)

261 The obligate intracellular pathogen Chlamydia trachomatis secretes effector proteins across

262 5 x 10(2) inclusion-forming units (IFUs) of Chlamydia trachomatis serovar D.

263 try/mass spectrometry (LC-MS/MS) analyses of Chlamydia trachomatis serovar L2 434/Bu EB, COMC, and Sa

264 cycle of the obligate intracellular pathogen Chlamydia trachomatis serovar L2 is controlled in part b

265 The two distinct lipoic acid ligases in Chlamydia trachomatis serovar L2, LplA1(Ct) and LplA2(Ct

266 .) routes with recombinant MOMP (rMOMP) from Chlamydia trachomatis serovars D (UW-3/Cx), E (Bour), or

267 fections caused by Neisseria gonorrhoeae and Chlamydia trachomatis serovars D to K occur at high inci

268 Chlamydia trachomatis serovars D-K are sexually transmit

269 Transformation of Chlamydia trachomatis should greatly advance the chlamyd

270 Transcription factor sigma(28) in Chlamydia trachomatis (sigma(28)(Ct)) plays a role in th

271 We now report that a Chlamydia trachomatis strain deficient in expression of

272 Chlamydia trachomatis strains are obligate intracellular

273 Previous studies identified specific Chlamydia trachomatis strains circulating among men who

274 erive the intact structure of the primordial Chlamydia trachomatis T3SS in the presence and absence o

275 id-based genetic transformation protocol for Chlamydia trachomatis that for the first time provides a

276 Clinical isolates of Chlamydia trachomatis that lack IncA on their inclusion

277 or infertility (TFI) that is attributable to Chlamydia trachomatis, the population excess fraction (P

278 nd include the agent of oculogenital disease Chlamydia trachomatis, the respiratory pathogen C. pneum

279 d mice infected with Chlamydia muridarum and Chlamydia trachomatis to determine if there were differe

280 ating between-strain genomic recombinants of Chlamydia trachomatis to facilitate the organism's evolu

281 Examination of the ability of Chlamydia trachomatis to prevent neutrophil apoptosis in

282 address the potential for plasmid-deficient Chlamydia trachomatis to serve as a live attenuated vacc

283 ted, we purified and analyzed three putative Chlamydia trachomatis topoisomerases.

284 haracterization of a previously undocumented Chlamydia trachomatis transcription factor, designated G

285 pants were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum (syphilis), he

286 The Chlamydia trachomatis type three-secreted effector prote

287 the lifetime was tested for the presence of Chlamydia trachomatis, type-specific human papillomaviru

288 The obligate intracellular human pathogen Chlamydia trachomatis undergoes a complex developmental

289 d as a model organism for the study of human Chlamydia trachomatis urogenital and respiratory tract i

290 ctive antimicrobial chemotherapy, control of Chlamydia trachomatis urogenital infection will likely r

291 Chlamydia trachomatis urogenital serovars replicate pred

292 During natural infections Chlamydia trachomatis urogenital serovars replicate pred

293 nd to a common Ag in Chlamydia muridarum and Chlamydia trachomatis Using an adoptive-transfer approac

294 urine samples) for Neisseria gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification t

295 nto the eukaryotic host cell is required for Chlamydia trachomatis virulence.

296 Chlamydia trachomatis was detected by the Amplicor PCR t

297 n a community with a high prevalence of STI, Chlamydia trachomatis was detected in 8.7% and Neisseria

298 An atypical response regulator, ChxR, from Chlamydia trachomatis, was previously reported to form h

299 Replicating Chlamydia trachomatis were labelled with these probes th

300 ndida albicans, Streptococcus agalactiae and Chlamydia trachomatis with a single biochip, enabling a